Dose response effect of conjugated equine oestrogen on blood pressure in postmenopausal women with hypertension

Blood Pressure

Volumn 9, Issue 5, 2000, Pages 275-282

  Harvey, P J ^a   Molloy, D ^a   Upton, J ^a   Wing, L M ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Ambulatory blood pressure; Blood pressure; Hypertension; Menopause; Oestrogen

Indexed keywords

CONJUGATED ESTROGEN; MEDROXYPROGESTERONE ACETATE;

ADULT; AMBULATORY MONITORING; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; ESTROGEN DEFICIENCY; ESTROGEN THERAPY; FEMALE; HUMAN; HYPERTENSION; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ALDOSTERONE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CIRCADIAN RHYTHM; CROSS-OVER STUDIES; DIASTOLE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; ESTROGENS, CONJUGATED (USP); FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; HYPERTENSION; MEDROXYPROGESTERONE 17-ACETATE; MIDDLE AGED; POSTMENOPAUSE; RENIN; SEX HORMONE-BINDING GLOBULIN; SYSTOLE;

EID: 0034538710     PISSN: 08037051     EISSN: None     Source Type: Journal    
DOI: 10.1080/080370500448669     Document Type: Article

References (54)

1. Cardiovascular risk in postmenopausal women: What is known and what is unknown
2. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: Final results of SHEP
3. The influence of menopause on blood pressure
4. The conventional and ambulatory blood pressure and menopause in a prospective population study
5. Intra-individual changes of blood pressure, serum lipids and body weight in relation to menstrual status: Results from a prospective population study in Goteborg, Sweden
6. Relationship between the menopause and risk factors for ischaemic heart disease
7. Some atherogenic concomitants of menopause. The Framingham Study
8. Impact of menopause status on blood pressure: WHO cardiac study
9. Natural and surgical menopause do not affect the trend of blood pressure - An 18 year follow-up study
10. Lack of influence of menopause on blood pressure and cardiovascular risk profile: A 16-year longitudinal study concerning a cohort of 568 women
11. Does the menopause play a role as a risk factor for essential hypertension?
12. Diet, menopause and serum cholesterol levels in women: The Framingham Study
13. Menopause-related changes in lipoproteins and some other cardiovascular risk factors
14. Relationship of menopause to serum cholesterol and arterial blood pressure: The United States Health Examination Survey of Adults
15. Early cardiac changes after menopause
16. Prevention and management of osteoporosis: Consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada 3. Effects of ovarian hormone therapy on skeletal and extra-skeletal tissues in women
17. Guide to preventive cardiology in women
18. The effects of different types and different doses of oestrogen replacement therapy on clinic and ambulatory blood pressure and the renin-angiotensin system in normotensive postmenopausal women
19. A prospective, controlled trial of six forms of hormone replacement therapy given to postmenopausal women
20. Blood pressure and hemodynamics in postmenopausal women during estradiol-17-beta substitution
21. The effect of type and dose of oestrogen on the blood pressure of post-menopausal women
22. An opposing view
23. Effect of natural oestrogens on blood pressure and weight in postmenopausal women
24. Effect of postmenopausal estrogen therapy on diastolic blood pressure and body weight
25. Percutaneous 17-beta-estradiol replacement therapy in hypertensive post menopausal women
26. The effect of hormone replacement therapy on blood pressure and cardiovascular risk factors in menopausal women with moderate hypertension
27. Hormone replacement therapy and blood pressure in hypertensive women
28. Effects of natural oestrogen therapy on blood pressure and the renin-angiotensin system in normotensive and hypertensive menopausal women
29. Estrogen replacement, vascular distensibility, and blood pressure in postmenopausal women
30. Effects of natural estrogen/gestagen and thiazide on coronary risk factors in normal postmenopausal women
31. Effects of acute administration of transdermal estrogen on postmenopausal women with systemic hypertension
32. 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension
33. Advice on contraception around the menopause
34. Endometrial thickness as measured by endovaginal ultrasonography for identifying endometrial abnormality
35. Changes in the use of hormone replacement therapy in South Australia
36. American National Standard for non-automated sphygmomanometers: Summary report
37. Elevated blood pressure during the first two hours of ambulatory blood pressure monitoring: A study comparing consecutive twenty-four-hour monitoring periods
38. Non-invasive registration of the arterial pulse waveform using high-fidelity applanation tonometry
39. Non-invasive determination of age-related changes in the human arterial pulse
40. Hypertension due to a renin secreting tumour localised by segmental renal vein sampling
41. A non-chromatographic non-extraction radioimmunoassay for serum aldosterone
42. On making multiple comparisons in clinical and experimental pharmacology and physiology
43. Distribution-free methods
44. Comparison of hepatic impact of oral and vaginal administration of ethinyl estradiol
45. Quantitative relationships of the pituitary-gonadal axis in postmenopausal women
46. Nitric oxide accounts for the dose-dependent estrogen-mediated coronary relaxation after acute estrogen withdrawal
47. Acute vascular effects of estrogen in postmenopausal women
48. Stimulation of prostacyclin biosynthetic activity by estradiol in rat aortic smooth muscle cells in culture
49. Induction of calcium-dependent nitric oxide synthases by sex hormones
50. Cardiovascular protection by oestrogen - A calcium antagonist effect?
51. Estrogen induced refractoriness to the pressor effects of infused angiotensin II
52. Comparison of pharmacodynamic properties of various estrogen formulations
53. Biological effects of various doses of conjugated equine estrogens in postmenopausal women